Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

  1. DPOH name: REYNOLDS, KAREN
Share this search Create an alert

Refine registrations results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (13)
Results: 1-13 | Export
  1. Cystic Fibrosis Canada / Fibrose kystique Canada
    Type: In-house Organization
    Occurred: 2024-02-05
    Posted: 2024-02-15
    Designated public office holders:
    • Jeffrey Skene, Director, Health Products and Food Branch, Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences | Health Canada (HC)
    • Karen Reynolds, Director General, Pharmaceutical Drugs Directorate, Health Products and Food Branch | Health Canada (HC)
    • Julie Dabrusin, Member of Parliament | House of Commons
    • Dan Albas, Member of Parliament | House of Commons
    • Andrew Taylor, Director, Policy, Research, and Data, Strategic Policy Branch, Office of Pharmaceuticals Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
  2. Parkinson Canada
    Type: In-house Organization
    Occurred: 2023-10-24
    Posted: 2023-11-14
    Designated public office holders:
    • Julie Dabrusin, Member of Parliament | House of Commons
    • Karen Reynolds, Director General, Health Products and Food Branch | Health Canada (HC)
    • Pamela Aung-Thin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    • Ben Carr, Member of Parliament | House of Commons
    • Karina Gould, Leader of the Government in the House of Commons, House of Commons | House of Commons
    Subject matters:
    • Health
  3. GlaxoSmithKline Inc.
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-04-17
    Posted: 2023-05-15
    Designated public office holders:
    • Karen Reynolds, Director General, Health Canada | Health Canada (HC)
    Subject matters:
    • Health
  4. Edmonton Global
    Type: In-house Organization
    Occurred: 2022-07-28
    Posted: 2022-08-15
    Designated public office holders:
    • Shelley Heidecker, Senior Business Officer | Prairies Economic Development Canada (PrairiesCan)
    • Bev Therrien, Manager, Entrepreneurship Programs and Partners | Prairies Economic Development Canada (PrairiesCan)
    • Megan Jarosch, Senior Advisor to the Assistant Deputy Minister | Prairies Economic Development Canada (PrairiesCan)
    • Karen Reynolds, Senior Business Officer | Prairies Economic Development Canada (PrairiesCan)
    Subject matters:
    • Economic Development
  5. Diabetes Canada / Diabète Canada
    Type: In-house Organization
    Occurred: 2020-02-24
    Posted: 2020-03-16
    Designated public office holders:
    • Karen Reynolds, Executive Director, STRATEGIC POLICY BRANCH | Health Canada (HC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Pierre Sabourin, ASSISTANT DEPUTY MINISTER, HEALTH PRODUCTS AND FOOD BRANCH | Health Canada (HC)
    Subject matters:
    • Health
  6. McKesson Canada
    Type: Consultant
    Lobbyist: Roberta Kramchynsky, StrategyCorp Inc.
    Occurred: 2020-01-14
    Posted: 2020-02-15
    Designated public office holders:
    • Abby Hoffman, Assistant Deputy Minister, Strategic Policy | Health Canada (HC)
    • Kendal Weber, Associate Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    • Pierre Sabourin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Stafania Trombetti, Assistant Deputy Minister, Regulatory, Operations and Enforcement Branch | Health Canada (HC)
    • Karen Reynolds, Executive Direct, Strategic Policy | Health Canada (HC)
    Subject matters:
    • Health
  7. Canadian Life and Health Insurance Association Inc. / Association canadienne des compagnies d'assurances de personnes inc.
    Type: In-house Organization
    Occurred: 2019-12-12
    Posted: 2020-01-13
    Designated public office holders:
    • Marcel Saulnier, Associate ADM, Strategic Policy | Health Canada (HC)
    • Karen Reynolds, Executive Director, Office of Pharmaceuticals Management Strategies, Strategic Policy | Health Canada (HC)
    Subject matters:
    • Health
  8. Diabetes Canada / Diabète Canada
    Type: In-house Organization
    Occurred: 2019-11-18
    Posted: 2019-12-16
    Designated public office holders:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Karen Reynolds, Executive Director, Strategic Policy Branch | Health Canada (HC)
    • Kendal Weber, Associate Assistant Deputy Minister, Health Products and Food | Health Canada (HC)
    Subject matters:
    • Aboriginal Affairs
    • Taxation and Finance
    • Health
  9. Arthritis Society Canada / Société de l’arthrite du Canada
    Type: In-house Organization
    Occurred: 2019-05-27
    Posted: 2019-06-13
    Designated public office holders:
    • Marcel Saulnier, Associate Deputy Minister | Health Canada (HC)
    • Karen Reynolds, Executive Director | Health Canada (HC)
    Subject matters:
    • Health
  10. Canadian American Business Council / Conseil Des Affairs Canado-Americaines
    Type: Consultant
    Lobbyist: MARYSCOTT GREENWOOD, Dentons
    Occurred: 2018-10-02
    Posted: 2018-11-15
    Designated public office holders:
    • Nadine Caron, Member, Council on Implementation of National PharmaCare | Health Canada (HC)
    • Mia Hornsy, Vice Chair, Council on Implementation of National PharmaCare | Health Canada (HC)
    • Karen Reynolds, Director of Policy, Secretariat, Council on Implementation of National PharmaCare | Health Canada (HC)
    • Eric Hoskins, Chairman, Council on Implementation of National PharmaCare | Health Canada (HC)
    • Dara McLeod, Deputy Executive Director, Secretariat, Council on Implementation of National PharmaCare | Health Canada (HC)
    • Marcel Saulnier, Executive Director, Secretariat, Council on Implementation of National PharmaCare | Health Canada (HC)
    Subject matters:
    • Economic Development
    • Consumer Issues
    • Intellectual Property
  11. Loblaw Companies Limited
    Type: In-house Corporation
    Occurred: 2018-09-12
    Posted: 2018-10-15
    Designated public office holders:
    • Karen Reynolds, Executive Director, OFFICE OF PHARMACEUTICALS MANAGEMENT STRATEGIES | Health Canada (HC)
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    • Marcel Saulnier, Executive Director, HEALTH CARE STRATEGIES DIRECTORATE | Health Canada (HC)
    Subject matters:
    • Consumer Issues
    • Health
  12. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Occurred: 2018-05-22
    Posted: 2018-06-15
    Designated public office holders:
    • Stephanie Hardy, Manager, Policy Unit, Health Products and Therapeutics Branch | Health Canada (HC)
    • Agnes Klein, Senior Medical Advisor, Health Products and Therapeutics Branch | Health Canada (HC)
    • Jemma Fraije, A/ Regulatory Affairs Supervisor, Health Products and Therapeutics Branch | Health Canada (HC)
    • Liz Anne Gillham-Eisen, A Director, Health Products and Therapeutics Branch | Health Canada (HC)
    • Jian Wang, Division Chief, Health Products and Therapeutics Branch | Health Canada (HC)
    • Lindsay Elmgren, Director, Centre for Biologics Evaluation, Health Products and Therapeutics Branch | Health Canada (HC)
    • Emily Griffiths, Subject Matter / Technical Specialist, Health Products and Therapeutics Branch | Health Canada (HC)
    • Cathy Parker, Director General, Health Products and Therapeutics Branch | Health Canada (HC)
    • Evelyn Soo, Associate to the Director General, Health Products and Therapeutics Branch | Health Canada (HC)
    • Georgette Roy, Director, Office of Regulatory Affairs, Health Products and Therapeutics Branch | Health Canada (HC)
    • Michele Chadwick, Manager, Health Products and Therapeutics Branch | Health Canada (HC)
    • Megan Bettle, Director, Health Products and Therapeutics Branch | Health Canada (HC)
    • Karen Reynolds, Executive Director, Strategic Policy Branch | Health Canada (HC)
    • Kelly Robinson, Director, Health Products and Therapeutics Branch | Health Canada (HC)
    • Johanne Veenstra, Senior Regulatory Officer, Health Products and Therapeutics Branch | Health Canada (HC)
    • Anthony Ridgway, Senior Regulatory Scientist, Health Products and Therapeutics Branch | Health Canada (HC)
    Subject matters:
    • Health
  13. Great-West Lifeco Inc.
    Type: In-house Corporation
    Occurred: 2017-02-23
    Posted: 2017-03-02
    Designated public office holders:
    • Lisa Thompson, Senior Policy Advisor, Strategic Pharmaceutical Initiatives, Strategic Policy Branch | Health Canada (HC)
    • Sheryl Harris, Policy Advisor, Health Care Strategies Directorate, Strategic Policy Branch | Health Canada (HC)
    • Karen Reynolds, Strategic Pharmaceutical Initiatives,, Strategic Policy Branch | Health Canada (HC)
    • Kendal Weber, Strategic Pharmaceutical Initiatives, Strategic Policy Branch | Health Canada (HC)
    • Garry Keller, Chief of Staff, Office of the Leader of the Official Opposition | House of Commons
    Subject matters:
    • Health

Date Modified: